Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 7,874 | 7,534 | 5,906 | 5,720 | 5,943 |
| Operating Income | -7,874 | -7,534 | -5,906 | -5,720 | -5,943 |
| Other Income | -4,971 | 12,917 | -19,493 | -1,920 | 39 |
| Pre-tax Income | -12,845 | 5,383 | -25,399 | -7,640 | -5,904 |
| Net Income Continuous | -12,845 | 5,383 | -25,399 | -7,640 | -5,904 |
| Net Income | $-12,845 | $5,383 | $-25,399 | $-7,640 | $-5,904 |
| EPS Basic Total Ops | -3.54 | 16.63 | -17.00 | -12.25 | -15.80 |
| EPS Basic Continuous Ops | -3.11 | 16.79 | -17.02 | -12.30 | -15.80 |
| EPS Diluted Total Ops | -3.54 | 16.63 | -17.00 | -12.25 | -15.80 |
| EPS Diluted Continuous Ops | -3.11 | 16.79 | -17.02 | -12.30 | -15.80 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -3.25 | -12.25 | -17.25 |
| EBITDA(a) | $-7,866 | $-7,525 | $-5,884 | $-5,692 | $-5,912 |